Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors

Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors

WOBURN, Massachusetts, June 11, 2018 /PRNewswire/ — Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Hyam I. Levitsky, M.D. to the company’s Board as an independent non-executive Director. “Hy is a leading expert in immuno-oncology with